| Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10 MC Béné, T Nebe, P Bettelheim, B Buldini, H Bumbea, W Kern, ... Leukemia 25 (4), 567-574, 2011 | 306 | 2011 |
| MALT lymphoma: epidemiology, clinical diagnosis and treatment PV Filip, D Cuciureanu, LS Diaconu, AM Vladareanu, CS Pop Journal of medicine and life 11 (3), 187, 2018 | 127 | 2018 |
| Idiopathic thrombocytopenic purpura (ITP)–new era for an old disease M Onisâi, AM Vlădăreanu, A Spînu, M Găman, H Bumbea Romanian Journal of Internal Medicine 57 (4), 273-283, 2019 | 87 | 2019 |
| A study of the hematological picture and of platelet function in preeclampsia-report of a series of cases. M Onisai, AM Vladareanu, H Bumbea, M Ciorascu, C Pop, C Andrei, ... Maedica-a Journal of Clinical Medicine 4 (4), 2009 | 49 | 2009 |
| MECOM, HBS1L‐MYB, THRB‐RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients AP Trifa, C Bănescu, AS Bojan, CM Voina, Ș Popa, S Vișan, AD Ciubean, ... American Journal of Hematology 93 (1), 100-106, 2018 | 45 | 2018 |
| TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms … AP Trifa, C Bănescu, M Tevet, A Bojan, D Dima, L Urian, T Török‐Vistai, ... British Journal of Haematology 174 (2), 218-226, 2016 | 43 | 2016 |
| LEAM vs. beam vs. CLV conditioning regimen for autologous stem cell transplantation in malignant lymphomas. retrospective comparison of toxicity and efficacy on 222 patients in … A Colita, A Colita, H Bumbea, A Croitoru, C Orban, LE Lipan, OG Craciun, ... Frontiers in Oncology 9, 892, 2019 | 41 | 2019 |
| Perinatal outcome for pregnancies complicated with thrombocytopenia M Onisâi, AM Vlădăreanu, C Delcea, M Ciorăscu, H Bumbea, A Nicolescu, ... The Journal of Maternal-Fetal & Neonatal Medicine 25 (9), 1622-1626, 2012 | 38 | 2012 |
| The impact of hepatitis viruses on chronic lymphoproliferative disorders; preliminary results AM Vladareanu, C Ciufu, AM Neagu, M Onisai, H Bumbea, AM Vintilescu, ... Journal of Medicine and Life 3 (3), 320, 2010 | 30 | 2010 |
| A challenging case of Kikuchi‐Fujimoto disease associated with systemic lupus erythematosus and review of the literature M Găman, AM Vlădăreanu, C Dobrea, M Onisâi, C Marinescu, I Voican, ... Case reports in hematology 2018 (1), 1791627, 2018 | 28 | 2018 |
| Chronic myeloid leukemia therapy in the era of tyrosine kinase inhibitors. The first molecular targeted treatment H Bumbea, AM Vladareanu, D Cisleanu, L Barsan, M Onisai, I Voican Journal of medicine and life 3 (2), 162, 2010 | 28 | 2010 |
| 2016 WHO clinical molecular and pathological criteria for classification and staging of myeloproliferative neoplasms (MPN) caused by MPN driver mutations in the JAK2, MPL and … JJ Michiels, M Tevet, A Trifa, E Niculescu-Mizil, A Lupu, AM Vladareanu, ... Maedica 11 (1), 5, 2016 | 25 | 2016 |
| Therapeutic options for immune thrombocytopenia (ITP) during pregnancy A Nicolescu, AM Vladareanu, I Voican, M Onisai, R Vladareanu Maedica 8 (2), 182, 2013 | 24 | 2013 |
| Effects of exogenous androgens on platelet activity and their thrombogenic potential in supraphysiological administration: a literature review AE Roşca, AM Vlădăreanu, A Mititelu, BO Popescu, C Badiu, C Căruntu, ... Journal of Clinical Medicine 10 (1), 147, 2021 | 22 | 2021 |
| Acute lymphocytic leukemia in adults. Pathologic features and prognosis C Marinescu, AM Vladareanu, F Mihai Romanian Journal Of Internal Medicine 53 (1), 33-38, 2015 | 22 | 2015 |
| 3D echocardiography, arterial stiffness, and biomarkers in early diagnosis and prediction of CHOP-induced cardiotoxicity in non-Hodgkin’s lymphoma D Mihalcea, M Florescu, R Bruja, N Patrascu, AM Vladareanu, ... Scientific Reports 10 (1), 18473, 2020 | 21 | 2020 |
| Splanchnic vein thrombosis, the onset manifestation in JAK positive chronic myeloproliferative disorders neoplasms AM Vladareanu, V Popov, H Bumbea, M Onisai, A Ilea, C Dobrea, ... Journal of Medicine and Life 4 (1), 97, 2011 | 16 | 2011 |
| Taurine and its derivatives: analysis of the inhibitory effect on platelet function and their antithrombotic potential AE Roşca, AM Vlădăreanu, R Mirica, CM Anghel-Timaru, A Mititelu, ... Journal of clinical medicine 11 (3), 666, 2022 | 15 | 2022 |
| Platelet defects in acute myeloid leukemia—potential for hemorrhagic events H Bumbea, AM Vladareanu, I Dumitru, VM Popov, C Ciufu, A Nicolescu, ... Journal of Clinical Medicine 11 (1), 118, 2021 | 13 | 2021 |
| Primary myelofibrosis and pregnancy outcomes after low molecular-weight heparin administration: A case report and literature review RE Bohîltea, MM Cîrstoiu, CA Ionescu, E Niculescu-Mizil, AM Vladareanu, ... Medicine 96 (46), e8735, 2017 | 13 | 2017 |
